We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Teladoc's (TDOC) Telemedicine Service to Improve Mental Health
Read MoreHide Full Article
Teladoc Health, Inc. (TDOC - Free Report) recently introduced Mental Health Care — the telemedicine service — that intends to offer improved mental health outcomes for Canadian employees. This initiative adds another feather to Teladoc Health’s diversified suite of mental health offerings in Canada. Notably, the company already has an established presence in the country with its Mental Health Navigator and disability products for addressing mental health issues.
What makes this telemedicine service noteworthy is that it can be called the first platform to collectively provide general medical and mental health care. Another notable feature is the benefit of virtual therapy offered by this new telemedicine service, which not only ensures confidential appointments but also provides essential treatment to those who have limited time availability or find it more secure in a controlled space.
Members of Mental Health Care will have access to Teladoc Health’s licensed psychiatrists, psychologists and therapists with whom they can have multiple sessions via any medium, which they find convenient like phone, web or mobile app.
Moreover, the same members will not only get an average of five-day lead time for booking appointments but will also have access to Mental Health Care on a 24-7 basis.
It has to be noted that mental health issues, aggravated further by the COVID-19 pandemic, have been rising alarmingly across the United States and Canada. With unemployment levels remaining high, financial burden is bound to take a toll on mental health of most people. Thus, addressing mental issues at the earliest has become crucial amid this pandemic.
A study conducted by Teladoc Health in May this year reported that the mental health of half of Canadian respondents were adversely affected by the pandemic, and most of them were in favor of opting for virtual care in order to resolve their mental health issues.
Furthermore, we believe that the launch of Mental Health Care comes at an opportune time and will be a boon for Canadian employers as most employees are emphasizing on employee benefit plans, which offer virtual care for mental health needs. Notably, the World Health Organization (WHO) has also stressed on the fact that workplaces need to address mental health issues of employees. The inability to do so often leads to lower productivity and absenteeism.
Teladoc Health has been banking on several initiatives to boost telehealth offerings. With stringent social distancing measures being observed on account of the coronavirus, patients have been compelled to resort to telehealth services in order to avail medical help. The pandemic has further highlighted the importance of telehealth services, and Teladoc Health is well poised to capitalize on the current scenario.
In sync with its endeavors, Teladoc Health decided to merge with Livongo Health, Inc. in August in order to create a comprehensive virtual healthcare delivery system. Among other stocks in the medical space, Magellan Health, Inc. and Humana Inc. (HUM - Free Report) have also developed telehealth services.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Shutterstock
Teladoc's (TDOC) Telemedicine Service to Improve Mental Health
Teladoc Health, Inc. (TDOC - Free Report) recently introduced Mental Health Care — the telemedicine service — that intends to offer improved mental health outcomes for Canadian employees. This initiative adds another feather to Teladoc Health’s diversified suite of mental health offerings in Canada. Notably, the company already has an established presence in the country with its Mental Health Navigator and disability products for addressing mental health issues.
What makes this telemedicine service noteworthy is that it can be called the first platform to collectively provide general medical and mental health care. Another notable feature is the benefit of virtual therapy offered by this new telemedicine service, which not only ensures confidential appointments but also provides essential treatment to those who have limited time availability or find it more secure in a controlled space.
Members of Mental Health Care will have access to Teladoc Health’s licensed psychiatrists, psychologists and therapists with whom they can have multiple sessions via any medium, which they find convenient like phone, web or mobile app.
Moreover, the same members will not only get an average of five-day lead time for booking appointments but will also have access to Mental Health Care on a 24-7 basis.
Shares of this Zacks Rank #3 (Hold) health care provider have soared 220.8% in a year compared with the industry’s rally of 42.5%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Addressing Mental Issues: Need of the Hour
It has to be noted that mental health issues, aggravated further by the COVID-19 pandemic, have been rising alarmingly across the United States and Canada. With unemployment levels remaining high, financial burden is bound to take a toll on mental health of most people. Thus, addressing mental issues at the earliest has become crucial amid this pandemic.
A study conducted by Teladoc Health in May this year reported that the mental health of half of Canadian respondents were adversely affected by the pandemic, and most of them were in favor of opting for virtual care in order to resolve their mental health issues.
Furthermore, we believe that the launch of Mental Health Care comes at an opportune time and will be a boon for Canadian employers as most employees are emphasizing on employee benefit plans, which offer virtual care for mental health needs. Notably, the World Health Organization (WHO) has also stressed on the fact that workplaces need to address mental health issues of employees. The inability to do so often leads to lower productivity and absenteeism.
Teladoc Health has been banking on several initiatives to boost telehealth offerings. With stringent social distancing measures being observed on account of the coronavirus, patients have been compelled to resort to telehealth services in order to avail medical help. The pandemic has further highlighted the importance of telehealth services, and Teladoc Health is well poised to capitalize on the current scenario.
In sync with its endeavors, Teladoc Health decided to merge with Livongo Health, Inc. in August in order to create a comprehensive virtual healthcare delivery system. Among other stocks in the medical space, Magellan Health, Inc. and Humana Inc. (HUM - Free Report) have also developed telehealth services.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>